GLP-1 Drugs Changed Peptide Manufacturing Forever: Here Is What the Industry Is Doing to Keep Up In June 2021, the FDA approved Wegovy, the semaglutide-based obesity treatment from Novo Nordisk, and the global pharmaceutical industry entered a chapter it was entirely unprepared for
Limited observational data and case reports suggest that GLP-1 receptor agonists do not adversely affect thyroid function in patients with pre-existing hypothyroidism who are maintained on stable levothyroxine therapy
Bastick, A
See how a little structure and the right guidance can make each week feel more manageable
Many patients notice improved clarity, hydration, and reduced pigmentation with consistent use
Beconi MG, Reed JR, Teffera Y, Xia YQ, Kochansky CJ, Liu DQ, et al